SEQUENTPharmaceuticals
Sequent Scientific Ltd — PE Ratio & Valuation Analysis
₹188.78
+0.00%
Current P/E129.57xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E149.5x13.3% below avg
⚠️
307.8% Premium to Industry
SEQUENT P/E 129.57x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.85 | ₹209 | 245.3x |
| 2022 | ₹1.63 | ₹88 | 53.7x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Sequent Scientific Ltd Valuation
Sequent Scientific Ltd (SEQUENT) currently trades at 129.57x earnings. The Pharmaceuticals sector average PE is 31.77x. SEQUENT commands a premium, reflecting high growth expectations. Historically, SEQUENT has traded at an average PE of 149.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
3.21%
Dividend Yield
0.00%
More on Sequent Scientific Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.